PRKCE and acute myeloid leukemia: Given that the data above are not supportive of an oncogenic role for PKCε overexpression in AML, we next examined the capacity of PKCε to promote chemoresistance in AML cells as this is a known consequence of PKCε overexpression in solid cancers (10, 41).